Perhaps combining this therapeutic approach with the development of small molecule agonists to TrkA to facilitate prosurvival signaling (Jang et al., 2007) or small molecule antagonists to p75NTR for anti-apoptotic actions should be added to the treatment toolbox for MCI and AD. Here, NGFR is linked to Alzheimer disease.